Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: Findings from the STEP-BD

American Journal of Psychiatry

Volumn 164, Issue 9, 2007, Pages 1348-1355

  Goldberg, Joseph F ^a   Perlis, Roy H ^a   Ghaemi, S Nassir ^a   Calabrese, Joseph R ^a   Bowden, Charles L ^a   Wisniewski, Stephen ^a   Miklowitz, David J ^a   Sachs, Gary S ^a   Thase, Michael E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; LAMOTRIGINE; LITHIUM; MIRTAZAPINE; MOOD STABILIZER; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; SERTRALINE; VALPROATE SEMISODIUM; VENLAFAXINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MECHANISM; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MONOTHERAPY; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL MODEL; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; COMBINED MODALITY THERAPY; COMORBIDITY; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LITHIUM COMPOUNDS; LONGITUDINAL STUDIES; MALE; PROPORTIONAL HAZARDS MODELS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; RECURRENCE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 34648827438     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.2007.05122032     Document Type: Article

References (37)

1. McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI, Faedda GL, Swann AC: Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry 1992; 149:1633-1644
2. Benazzi F: Family history validation of a definition of mixed depression. Compr Psychiatry 2005; 46:159-166
3. Perugi G, Akiskal HS, Micheli C, Toni C, Madaro D: Clinical characterization of depressive mixed state in bipolar I patients: Pisa-San Diego Collaboration. J Affect Disord 2001; 67:105-114
4. Benazzi F: Mixed states in bipolar II disorder: should full hypomania always be required? Psychiatry Res 2004; 127:247-257
5. Sato T, Bottlender R, Sievers M, Moller HJ: Evidence of depressive mixed states. Am J Psychiatry 2005; 162:193-194
6. Cassidy F, Ahearn EP, Carroll BJ: Symptom profile consistency in recurrent manic episodes. Compr Psychiatry 2002; 43:179-181
7. Sato T, Bottlender R, Sievers M, Schroter A, Kleindienst N, Moller HJ: Evaluating the inter-episode stability of depressive mixed states. J Affect Disord 2004; 81:103-113
8. Sato T, Bottlender R, Kleindienst N, Tanabe A, Moller HJ: The boundary between mixed and manic episodes in the ICD-10 classification. Acta Psychiatr Scand 2002; 106:109-116
9. Bauer MS, Callahan AM, Jampala C, Petty F, Sajatovic M, Schaefer V, Wittlin B, Powell BJ: Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs. J Clin Psychiatry 1999; 60:9-21
10. Sachs G, Printz D, Kahn D, Carpenter D, Docherty JP: The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder. Postgrad Med 2000; Spec No: 1-104
11. American Psychiatric Association: Practice Guideline for the Treatment of Patients With Bipolar Disorder (revision). Am J Psychiatry 2002; 159:1-50
12. Suppes T, Dennehy EB, Hirschfeld RM, Altshuler LL, Bowden CL, Calabrese JR, Crismon ML, Ketter TA, Sachs GS, Swann AC, Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder: The Texas Implementation of Medication Algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry 2005; 66:870-886
13. Swann AC, Bowden CL, Morris D, Calabrese JR, Petty F, Small J, Dilsaver SC, Davis JM: Depression during mania: treatment response to lithium or divalproex. Arch Gen Psychiatry 1997; 54: 37-42
14. Clothier J, Swann AC, Freeman T: Dysphoric mania. J Clin Psychopharmacol 1992; 12(suppl 1):13S-16S
15. Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L, Friedman ES, Bowden CL, Fossey MD, Ostacher MJ, Ketter TA, Patel J, Hauser P, Rapport D, Martinez JM, Allen MH, Miklowitz MJ, Otto MW, Dennehy EB, Thase ME: Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007; 356:1711-1722
16. Sachs GS, Thase ME, Otto MW, Bauer M, Miklowitz D, Wisniewski SR, Lavori P, Lebowitz B, Rudorfer M, Frank E, Nierenberg AA, Fava M, Bowden C, Ketter T, Marangell L, Calabrese J, Kupfer D, Rosenbaum M: Rationale, design, and methods of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Biol Psychiatry 2003; 53:1028-1042
17. Bauer MS, Whybrow PC, Gyulai L, Gonnel J, Yeh HS: Testing definitions of dysphoric mania and hypomania. J Affect Disord 1994; 32:201-211
18. Bauer MS, Simon GE, Ludman E, UnutzerJ: "Bipolarity" in bipolar disorder: distribution of manic and depressive symptoms in a treated population. Br J Psychiatry 2005; 187:87-88
19. Sheehan D, Lecrubier Y, Sheehan H, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatrie Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59:22-33
20. Sachs GS, Guille C, McMurrich S: A clinical monitoring form for mood disorders. Bipolar Disord 2002; 4:323-327
21. Young RC, Biggs JT, Ziegler VT, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133:429-435
22. Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382-389
23. Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, Ketter TA, Miklowitz DJ, Otto MW, Gyulai L, Reilly-Harrington NA, Nierenberg AA, Sachs GS, Thase ME: Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2006; 163:217-224
24. Keller MB, Lavori PW, Coryell W, Endicott J, Mueller IT: Bipolar I: a five-year prospective follow-up. J Nerv Ment Dis 1993; 181: 238-245
25. Weiss RD, Ostacher MJ, Otto MW, Calabrese JR, Fossey M, Wisniewski SR, Bowden CL, Nierenberg AA, Pollack MH, Salloum IM, Simon NM, Thase ME, Sachs GS; for STEP-BD Investigators: Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry 2005; 66:730-735
26. Goldberg JF, Truman CJ: Antidepressant-induced mania: an overview of current controversies. Bipolar Disord 2003; 5:407-420
27. MacQueen GM, Young LT, Marriott M, Robb J, Begun H, Joffe RT: Previous mood state predicts response and switch rates in patients with bipolar depression. Acta Psychiatr Scand 2002; 105: 414-418
28. Prien RF, Himmelhoch JKM, Kupfer DJ: Treatment of mixed mania. J Affect Disord 1988; 15:9-15
29. Goldberg JF, Garno JL, Kocsis JH, Leon AC, Portera L, Whiteside JE: Correlates of suicidal ideation in dysphoric mania. J Affect Disord 1999; 56:75-81
30. Fagiolini A, Frank E, Cherry CR, Houck PR, Novick DM, Buysse DJ, Kupfer DJ: Clinical indicators for the use of antidepressants in the treatment of bipolar I depression. Bipolar Disord 2002; 4:277-282
31. Goldberg JF, Garno JL, Leon AC, Kocsis JH, Portera L: Qualitative differences in mixed versus pure mania. Compr Psychatry 2000; 4:237-241
32. Young LT, Joffe RT, Robb JC, MacQueen GM, Marriott M, Patelis-Siotis I: Double-blind comparison of adding a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry 2000; 157:124-126
33. Nemeroff CB, Evans DL, Gyulai L, Sachs GS, Bowden CL, Gergel IP, Oakes R, Pitts CD: Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001; 158:906-912
34. Altshuler L, Suppes T, Black D, Nolen WA, Keck PE Jr, Frye MA, McElroy S, Kupka R, Grunze H, Waiden J, Leverich G, Denicoff K, Luckenbaugh D, Post R: Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry 2003; 160: 1252-1262
35. Joffe TR, MacQueen GM, Marriott M, Young LT: One-year outcome with antidepressant-treatment of bipolar depression. Acta Psychiatr Scand 2005; 112:105-109
36. Goldberg JF, Garno JL, Leon AC, Kocsis JH, Portera L: Association of recurrent suicidal ideation with nonremission from acute mixed mania. Am J Psychiatry 1998; 155:1753-1755
37. Sato T, Bottlender R, Tanabe A, Moller HJ: Cincinnati criteria for mixed mania and suicidality in patients with acute mania. Compr Psychiatry 2004; 45:62-69